Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
Authors:
- Natalya RisinskayaNRNatalya Risinskaya
- Yana KozhevnikovaYKYana Kozhevnikova
- Olga GavrilinaOGOlga Gavrilina
- Julia ChabaevaJCJulia Chabaeva
- Ekaterina KotovaEKEkaterina Kotova
- Anna YushkovaAYAnna Yushkova
- Galina IsinovaGIGalina Isinova
- Ksenija ZarubinaKZKsenija Zarubina
- Tatiana ObukhovaTOTatiana Obukhova
- Sergey KulikovSKSergey Kulikov
- Hunan JulhakyanHJHunan Julhakyan
- Andrey SudarikovASAndrey Sudarikov
Open Access
Abstract
Despite the introduction of new technologies in molecular diagnostics, one should not underestimate the traditional routine methods for studying tumor DNA. Here we present the evidence that short tandem repeat (STR) profiling of tumor DNA relative to DNA from healthy cells might identify chromosomal aberrations affecting therapy outcome. Tumor STR profiles of 87 adult patients with de novo Ph-negative ALL (40 B-ALL, 43 T-ALL, 4 mixed phenotype acute leukemia (MPAL)) treated according to the “RALL-2016” regimen were analyzed. DNA of tumor cells was isolated from patient bone marrow samples taken at diagnosis. Control DNA samples were taken from the buccal swab or the blood of patients in complete remission. Overall survival (OS) analysis was used to assess the independent impact of the LOH as a risk factor. Of the 87 patients, 21 were found with LOH in various STR loci (24%). For B-ALL patients, LOH (except 12p LOH) was an independent risk factor (OS hazard ratio 3.89, log-rank p-value 0.0395). In contrast, for T-ALL patients, the OS hazard ratio was 0.59 (log-rank p-value 0.62). LOH in particular STR loci measured at the onset of the disease could be used as a prognostic factor for poor outcome in B-ALL, but not in T-ALL.Keywords
Funding Information
- RAKFOND (5.2019)
This publication has 35 references indexed in Scilit:
- Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/LymphomaThe Journal of Molecular Diagnostics, 2016
- Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical OutcomePLOS ONE, 2016
- Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyCancer Genetics, 2015
- Pathogenesis and Consequences of Uniparental Disomy in CancerClinical Cancer Research, 2011
- Mutational Dynamics of MicrosatellitesMolecular Biotechnology, 2009
- Cytogenetics and Molecular Genetics of Acute Lymphoblastic LeukemiaHematology/Oncology Clinics of North America, 2009
- An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patientsHaematologica, 2008
- Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 2004
- Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemiaLeukemia, 2003
- The importance of cytogenetic studies in adult acute lymphocytic leukemiaThe American Journal of Medicine, 1990